Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Verve Therapeutics Inc..
Verve Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Verve Therapeutics Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Verve Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Verve Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Verve Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Verve Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Verve Therapeutics Inc.- Key Facts
2.2 Verve Therapeutics Inc.- Geographic Locations
2.3 Verve Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Verve Therapeutics Inc.- Business Divisions
2.5 Verve Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Verve Therapeutics Inc. Strategic Analysis Review
3.1 Verve Therapeutics Inc.- Key Strategies
3.2 Verve Therapeutics Inc.- Company Outlook Statement
3.3 Verve Therapeutics Inc.- SWOT Analysis
3.3.1 Verve Therapeutics Inc.- Key Strengths
3.3.2 Verve Therapeutics Inc.- Key Weaknesses
3.3.3 Verve Therapeutics Inc.- Potential Opportunities
3.3.4 Verve Therapeutics Inc.- Potential Threats
3.4 Verve Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Verve Therapeutics Inc.- Business Overview
4.2 Verve Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Verve Therapeutics Inc.- Key Products
5.2 Verve Therapeutics Inc.- Key Service Areas
5.3 Verve Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Verve Therapeutics Inc.- Company History
6.2 Verve Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Verve Therapeutics Inc.- Income Statements
7.2 Verve Therapeutics Inc.- Balance Sheet
7.3 Verve Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Verve Therapeutics Inc.- Direct Competitors
8.2 Verve Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Verve Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Verve Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!